PROMinsight is a world leader in contemporary measurement of
patient-reported outcomes.
We provide the most sophisticated and comprehensive patient-reported outcome measures (PROMs) for researchers, clinicians, industry partners, and tertiary eye centres to assess the quality of life impact of eye conditions and vision impairment, and the patient-centred effectiveness of related treatments.
With over two decades of research experience and hundreds of peer-reviewed publications on patient-reported outcomes, we are leaders in the field and pioneers in personalised eye-related PROM testing.
Our internationally recognised team has developed several validated PROMs in ophthalmology and offers expert consultancy on a range of topics relating to test development, questionnaire administration, study design, research methods, and data analysis.
WE ARE PASSIONATE ABOUT
Understanding the quality of life impact of eye conditions, vision loss and how treatments can benefit the patient’s daily living experience
Building superior tools to help measure patient-reported outcomes
Providing industry partners with innovative PROM testing solutions to better assess the patient-centred effectiveness of novel treatment interventions
Supporting tertiary eye institutes to integrate personalised, online PROMs within their healthcare system, in line with value-based medical care
OUR LEADERSHIP TEAM
Assoc. Prof. Eva Fenwick,
BA (Hons), MA, PhD
Co-Founder, Chief Executive Officer
Dr. Eva Fenwick is an international authority on PROM development, validation and implementation, with expertise in qualitative and quantitative research, and psychometrics. With a PhD in item banking and CAT and over 200 publications in international peer-reviewed journals, Dr. Eva Fenwick leads PROMinsight as CEO, overseeing the scientific, research, and technological operations while driving the strategic development and growth of our advanced PROM solutions. Dr Eva Fenwick also holds an Adjunct Associate Professor at Duke-NUS Medical School
Prof. Ecosse Lamoureux,
B.Ed, Grad. Dip. MSc, PhD
Co-Founder, Chief Scientific Advisor
Professor Lamoureux is a senior clinician scientist with
the Singapore Eye Research Institute; and holds a tenured appointment with the
Duke-NUS Medical School, Singapore and professorial appointments with the
National University of Singapore and the University of Melbourne, Australia. He
is a world-renowned expert on PROMs development, validation and implementation associated
with age-related eye diseases and diabetes. With over 500 publications in top
international journals, countless invitations to conferences and expert panels,
and hundreds of clinician, and academic collaborators, Prof Lamoureux drives
the scientific development and research direction of PROMinsight
OUR VISION
Our vision is to revolutionise how patient-reported outcomes are measured in research, clinical trials, and healthcare.
OUR MISSION
PROMInsight creates comprehensive and sophisticated measurement tools that allow researchers, healthcare professionals and industry partners to effectively assess the impact of eye disease, vision impairment and treatments from the patient’s perspective.
OUR COLLABORATORS
OUR COLLABORATORS
